All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IMP4927Phase 31 trial

    Impact Therapeutics, Inc. · Ovarian Cancer

  • INBRX-106OrdastobartPhase 31 trial

    Inhibrx Biosciences, Inc · Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

  • INCB161734Phase 31 trial

    Incyte · Solid Tumors

  • include docetaxelPhase 31 trial

    Shanghai Runshi Pharmaceutical Technology Co., Ltd · Advanced Oesophageal Squamous Cell Carcinoma

  • INT230-6Phase 31 trial

    Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • IptilimumabPhase 31 trial

    InSightec · Brain Tumor, Non Small Cell Lung Cancer

  • JMKX001899Phase 31 trial

    Jemincare · NSCLC (Non-small Cell Lung Cancer)

  • JNJ-87189401Phase 31 trial

    Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms

  • JYP0035Phase 31 trial

    Chengdu JOYO pharma Co., Ltd. · Breast Cancer

  • LerotinibZ650Phase 31 trial

    Sunshine Lake Pharma Co., Ltd. · Esophageal Cancer

  • LNS8801Phase 31 trial

    Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • LY01015Phase 31 trial

    Shandong Boan Biotechnology Co., Ltd · Esophageal Squamous Cell Carcinoma

  • MB11Proposed Nivolumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Advanced (Unresectable or Metastatic) Melanoma

  • MB12Proposed Pembrolizumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer

  • MRG002Phase 31 trial

    Shanghai Miracogen Inc. · Advanced or Metastatic Urothelium Cancer

  • MRG004APhase 31 trial

    Lepu Biopharma Co., Ltd. · Advanced Pancreatic Cancer

  • NB003Phase 31 trial

    Ningbo Newbay Technology Development Co., Ltd · GIST - Gastrointestinal Stromal Tumor, Advanced

  • New of NiraparibPhase 31 trial

    Johnson & Johnson (Janssen) · Castration-Resistant Prostatic Cancer

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • NofazinlimabPhase 31 trial

    CStone Pharmaceuticals · Hepatocellular Carcinoma

  • NP-101Phase 31 trial

    Novatek Pharmaceuticals · Gastroenteropancreatic Neuroendocrine Tumors

  • NRT6003Yttrium-90 carbon microspheresPhase 31 trial

    Chengdu New Radiomedicine Technology Co. LTD. · Unresectable Hepatocellular Carcinoma

  • NTQ1062Phase 31 trial

    Nanjing Chia-tai Tianqing Pharmaceutical · HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer

  • Olaparib phasePhase 31 trial

    AstraZeneca · Advanced or Recurrent Endometrial Cancer

  • PaxlitaxelPhase 31 trial

    Akeso · Advanced Squamous Non Small Cell Lung Cancer

  • PF04518600Phase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • PlinabulinPhase 31 trial

    BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance

  • ponsegromabPhase 31 trial

    Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

  • prolgolimabBCD-100, FortecaPhase 31 trial

    Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III

  • PRV111Cisplatin Transmucosal SystemPhase 31 trial

    Privo Technologies · Oral Squamous Cell Carcinoma

  • PRV131Cisplatin IntratumoralPhase 31 trial

    Privo Technologies · Oral Squamous Cell Carcinoma

  • PRV211Intraoperative Cisplatin SystemPhase 31 trial

    Privo Technologies · Oral Squamous Cell Carcinoma

  • QL1604Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer

  • QLG1080Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Prostate Cancer

  • RilogrotugPhase 31 trial

    AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome

  • RinzimetostatORIC-944Phase 31 trial

    ORIC Pharmaceuticals · Metastatic Castration Resistant Prostate Cancer

  • RPH-051Phase 31 trial

    R-Pharm · Locally Advanced Breast Cancer, Metastatic Breast Cancer

  • RulonilimabPhase 31 trial

    Shandong New Time Pharmaceutical Co., LTD · Cervical Cancer

  • SasanlimabPF-06801591Phase 31 trial

    Pfizer · Non-muscle Invasive Bladder Cancer

  • SB27Phase 31 trial

    Samsung Bioepis Co., Ltd. · Non-small Cell Lung Cancer Stage IV

  • SBP-101ivospeminPhase 31 trial

    Panbela Therapeutics, Inc. · Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV

  • SGM-101Phase 31 trial

    Surgimab · Colorectal Neoplasms

  • SH-1028Phase 31 trial

    Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer

  • SH006Phase 31 trial

    Nanjing Sanhome Pharmaceutical, Co., Ltd. · Hepatocellular Carcinoma (HCC)

  • SHR6390Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer

  • SIM0270Phase 31 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Locally Advanced or Metastatic Breast Cancer

  • SocazolimabPhase 31 trial

    Lee's Pharmaceutical Limited · Cervical Cancer

  • SRG-514Phase 31 trial

    SURGE Therapeutics · TNBC - Triple-Negative Breast Cancer

  • SurufatinibPhase 31 trial

    Hutchmed · Metastatic Pancreatic Cancer

NewerPage 8 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.